Elevated expression of IL-6 is inversely correlated with the survival time of glioma patients, and IL-6 is involved in glioma growth, angiogenesis, and resistance to chemotherapy, radiation, and apoptosis (15–17). The gene discussed is IL6; the disease is central nervous system cancer.